Kbc Group Nv Amicus Therapeutics, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 7,034 shares of FOLD stock, worth $67,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,034

Previous 6,830 2.99%

Holding current value

$67,456

Previous $68,000 10.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$9.55 - $12.09 $1,948 - $2,466	204 Added 2.99%	7,034 $75,000
Q2 2024 Jul 17, 2024	BUY	$9.04 - $11.75 $16,326 - $21,220	1,806 Added 35.95%	6,830 $68,000
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $50,089 - $72,948	5,024 New	5,024 $71,000
Q4 2019 Feb 11, 2020	SELL	$7.48 - $10.75 $51,312 - $73,745	-6,860 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$8.02 - $13.25 $50,044 - $82,680	6,240 Added 1006.45%	6,860 $55,000
Q2 2019 Dec 03, 2019	BUY	$10.96 - $14.4 $6,795 - $8,928	620 New	620 $8,000
Q2 2019 Jul 30, 2019	SELL	$10.96 - $14.4 $6,795 - $8,928	-620 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$10.04 - $13.92 $6,224 - $8,630	620 New	620 $8,000
Q1 2019 May 10, 2019	SELL	$10.04 - $13.92 $6,224 - $8,630	-620 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$8.38 - $13.44 $5,195 - $8,332	620 New	620 $6,000
Q4 2018 Jan 31, 2019	SELL	$8.38 - $13.44 $5,195 - $8,332	-620 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$11.6 - $16.54 $7,192 - $10,254	620 New	620 $7,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $7,192 - $10,254	-620 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$13.13 - $17.09 $8,140 - $10,595	620 New	620 $10,000
Q2 2018 Aug 03, 2018	SELL	$13.13 - $17.09 $8,140 - $10,595	-620 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$13.76 - $17.12 $8,531 - $10,614	620 New	620 $9,000
Q1 2018 May 09, 2018	SELL	$13.76 - $17.12 $8,531 - $10,614	-620 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$12.51 - $16.24 $7,756 - $10,068	620	620 $9,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account